The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.
Age range
40 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Assess if BBB function has been repaired.
Timeframe: After 3 months
Analyze blood serum S100β levels.
Timeframe: After 3 months
Examine cognition in T2DM adults with thiamine treatment.
Timeframe: After 3 months
Cognition assessment in T2DM adults after thiamine treatment.
Timeframe: After 3 months
Examine depression in T2DM adults with thiamine treatment.
Timeframe: After 3 months
Assess anxiety in T2DM adults with thiamine treatment.
Timeframe: After 3 months